Biotech

All Articles

ReNeuron leaving behind intention exchange after missing fundraising target

.ReNeuron has participated in the long checklist of biotechs to leave behind London's objective stoc...

MBX files for IPO to take opposition to Ascendis right into stage 3

.MBX Biosciences has contributed to the current outbreak of IPO filings. The biotech, which filed it...

FDA broadens probe into Lykos' MDMA trials: WSJ

.For Lykos Therapeutics and the company's would-be MDMA-assisted therapy for trauma (PTSD), the favo...

Gene editor Volume giving up 131 workers

.Just times after gene publisher Tome Biosciences declared unrevealed functional cuts, a clearer pho...

Repare gives up 25% of workers as biotech halts preclinical R&ampD

.Repare Rehab is laying off a quarter of its own staff as the oncology biotech downsize its own prec...

J &amp J files for FDA confirmation of $6.5 B autoimmune drug

.Johnson &amp Johnson has taken one more measure toward recognizing a return on its own $6.5 billion...

Gain's phase 1 succeed paves way to show Parkinson's medicine's worth

.Gain Therapies has actually set its sights on verifying the performance of its own Parkinson's illn...

Actinogen files new period 2 records to restore anxiety medication

.Actinogen Medical's hopes-- and inventory price-- have recoiled a little from previously this month...

Pfizer and also Main incorporate Ratio to multibillion-dollar formula

.Front Runner Pioneering and also Pfizer have added Quotient right into their 10-program alliance, i...

Bayer markers $547M deal to push boundaries of noncoding RNA

.Bayer executives were actually keen to stress and anxiety to Intense this summer months that the Ge...